The document contains important disclosures from William Blair & Company, LLC regarding their market making activities, investment banking intentions, and stock ratings. It includes a rating distribution for ARIAD Pharmaceuticals, Inc. and outlines the compensation structure for research analysts.
doj/DataSet10/EFTA01450731.pdf
{"title":"William Blair & Company, LLC. Important Disclosures","key_people":["Y. Katherine Xu"],"document_date":"2013-11-30","document_type":"other","document_subtype":"financial report","key_organizations":["William Blair & Company, LLC","ARIAD Pharmaceuticals, Inc."],"reference_numbers":["DB-SDNY-0106556","SDNY_GM_00252740","EFTA01450731"]}